4//SEC Filing
Wright-Mitchell Jane 4
Accession 0001209191-21-051631
CIK 0001649094other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:31 PM ET
Size
8.9 KB
Accession
0001209191-21-051631
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Mitchell Jane Wright
General Counsel
Transactions
- Sale
Common Stock
2021-08-12$26.00/sh−10,000$260,000→ 3,125 total - Exercise/Conversion
Common Stock
2021-08-12$2.03/sh+10,000$20,300→ 13,125 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-12−10,000→ 189,968 totalExercise: $2.03Exp: 2029-03-20→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Includes 1,563 shares acquired under the Employment Stock Purchase Plan on May 17, 2021.
- [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F3]1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001614568
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:31 PM ET
- Size
- 8.9 KB